Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Financing Activities: 2011-2025

Historic Cash from Financing Activities for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to $3.0 million.

  • Sonoma Pharmaceuticals' Cash from Financing Activities rose 1952.27% to $2.4 million in Q1 2013 from the same period last year, while for Mar 2013 it was $3.8 million, marking a year-over-year increase of 8.73%. This contributed to the annual value of $3.0 million for FY2025, which is 80.79% up from last year.
  • Sonoma Pharmaceuticals' Cash from Financing Activities amounted to $3.0 million in FY2025, which was up 80.79% from $1.7 million recorded in FY2024.
  • Sonoma Pharmaceuticals' Cash from Financing Activities' 5-year high stood at $7.4 million during FY2022, with a 5-year trough of $1.7 million in FY2024.
  • For the 3-year period, Sonoma Pharmaceuticals' Cash from Financing Activities averaged around $2.4 million, with its median value being $2.5 million (2023).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 221.48% in 2021, then tumbled by 66.35% in 2023.
  • Over the past 5 years, Sonoma Pharmaceuticals' Cash from Financing Activities (Yearly) stood at $3.3 million in 2021, then spiked by 123.58% to $7.4 million in 2022, then crashed by 66.35% to $2.5 million in 2023, then crashed by 32.66% to $1.7 million in 2024, then surged by 80.79% to $3.0 million in 2025.